PTSD Research Study
Researchers at the San Francisco VA Medical Center and NCIRE are partnering with individuals who experience PTSD symptoms, nightmares or who have a history of exposure to trauma. Join our compensated study today!
Fast Facts
PTSD Symptoms OR History of Exposure to Trauma
No history of any psychiatric disorder with active psychosis or mania in the past 5 years
18-65 years old
Compensation Provided
remote
Study Visits
Study Background
The San Francisco VA Medical Center and NCIRE are partnering with individuals who experience PTSD symptoms, nightmares or who have a history of exposure to trauma. The purpose of this study is to examine the effects of Doxazosin on sleep quality based on objective measures of sleep and sleep/wake activity.
Your expected time in this study will be 8 weeks on study drug, 6 virtual visits including a baseline and end-of-treatment interviews.
Further research and participate in PTSD clinical research study. Click here to learn more!
Study Background
The San Francisco VA Medical Center and NCIRE are partnering with individuals who experience PTSD symptoms, nightmares or who have a history of exposure to trauma. The purpose of this study is to examine the effects of Doxazosin on sleep quality based on objective measures of sleep and sleep/wake activity.
Your expected time in this study will be 8 weeks on study drug, 6 virtual visits including a baseline and end-of-treatment interviews.
Further research and participate in PTSD clinical research study. Click here to learn more!
Additional Information
The purpose of this study is to examine the effects of Doxazosin on sleep quality based on objective measures of sleep and sleep/wake activity.
You may qualify for this study if you meet the following criteria.
Key Criteria:
- Experiencing PTSD symptoms OR nightmares OR have a history of exposure to trauma
- 18-65 years old
- No history of any psychiatric disorder with active psychosis or mania in the past 5 years
Your expected time in this study will be 8 weeks on study drug, 6 virtual visits including a baseline and end-of-treatment interviews.
